InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+21.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Bruhn Suzanne Louise, Director. Insider active across 3 companies, notably Travere Therapeutics, Inc.. Aggregated, 10 disclosures have been published. Activity tracked since 14 May 2021. The latest transaction was disclosed on 19 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
4,000 shares0Common StockSEC:0001517790-26-000002:0
5,000 shares0Common StockSEC:0000950170-25-077274:0
6,500 shares0Common StockSEC:0001415889-25-013497:0
6,500 shares0Common StockSEC:0001415889-24-012845:0
13,671 shares0Common SharesSEC:0000899243-23-016417:0
4,500 shares0Common StockSEC:0001209191-23-030949:0
89,286 shares0Common SharesSEC:0000899243-22-028727:0
3,000 shares0Common StockSEC:0001209191-22-028686:0
3,000 shares0Common StockSEC:0001209191-21-033854
3,000 shares0Common StockSEC:0001209191-21-033854:0
10 of 10 declarations
About Bruhn Suzanne Louise
Suzanne Louise Bruhn is a Board Member at Travere Therapeutics, Inc. In this role, she participates in corporate governance and strategic decision-making. Bruhn is involved in performance evaluation and overseeing the company's activities to ensure its growth.
